Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida speciesĽuboš Drgoňa, Rosemary A. Barnes, A. Khachatryan et al.|European Journal of Clinical Microbiology & Infectious Diseases|2013Cited by 130
Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans Health AdministrationMonica Schaefer, Anthony P. Morreale, Jennifer Stephens et al.|Current Medical Research and Opinion|2004Cited by 18
Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: Physician knowledge, patient adherenceCaitlyn T. Solem, Xīn Gào, Reema Mody et al.|Journal of the American Pharmacists Association|2014Cited by 10